Regulation of Cellular Cholesterol Through Oxysterol-Membrane Interactions

通过氧甾醇-膜相互作用调节细胞胆固醇

基本信息

  • 批准号:
    8141358
  • 负责人:
  • 金额:
    $ 4.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Tight regulation of cellular and plasma cholesterol is crucial to proper cellular functioning, as excess free cholesterol is toxic to cells and is associated with atherosclerosis and heart disease. Cellular cholesterol homeostasis is regulated by enzymatically formed oxygenated cholesterol derivatives called oxysterols. Oxysterols can suppress expression of genes responsible for de novo cholesterol synthesis and lipoprotein cholesterol uptake, and serve as endogenous ligands for nuclear receptors, which activate cholesterol catabolic and efflux pathways. While the importance of oxysterols in the acute regulation of cholesterol homeostasis is known, the precise molecular mechanisms through which oxysterols exert their effects remain to be elucidated. My central hypothesis is that oxysterols exert their cholesterol-regulatory effects through non- enantioselective membrane-disordering effects. To test this hypothesis, I will (1) synthesize both the natural (nat) and enantiomeric (ent) forms of LY295427-a known antagonist of 25-HC, (2) examine the enantioselectivity of nat- and ent-LY295427-membrane interactions and the effect of LY295427 on the membrane-disordering properties of 25-HC, and (3) determine the enantioselectivity of LY295427 inhibition of 25-HC-mediated sterol homeostatic responses in cultured cells. The long-term objectives of this project are to elucidate the molecular mechanisms underlying the maintenance of cellular cholesterol balance, and to provide insight into how alteration in membrane structure can be used to relay regulatory signals. The proposed studies may help to identify pharmacological targets for manipulation of the cellular handling of cholesterol and treatment of atherosclerosis. PUBLIC HEALTH RELEVANCE: High levels of plasma lipoprotein cholesterol (e.g., in the form low-density lipoproteins (LDL), are associated with atherosclerosis and heart disease. Understanding the mechanisms through which cellular and whole-body cholesterol levels are regulated will provide new approaches to developing cholesterol-lowering treatments, and may reduce cardiovascular disease.
描述(由申请人提供):细胞和血浆胆固醇的严格调节对于细胞的正常功能至关重要,因为过量的游离胆固醇对细胞有毒,并且与动脉粥样硬化和心脏病有关。细胞胆固醇稳态由酶促形成的氧化胆固醇衍生物(称为氧甾醇)调节。氧甾醇可以抑制负责胆固醇从头合成和脂蛋白胆固醇摄取的基因的表达,并作为核受体的内源配体,激活胆固醇分解代谢和外流途径。虽然氧甾醇在胆固醇稳态的急性调节中的重要性是已知的,但氧甾醇发挥其作用的精确分子机制仍有待阐明。我的中心假设是氧甾醇通过非对映选择性膜紊乱作用发挥其胆固醇调节作用。为了检验这一假设,我将 (1) 合成 LY295427(一种已知的 25-HC 拮抗剂)的天然 (nat) 和对映体 (ent) 形式,(2) 检查天然 LY295427 和 ent-LY295427 膜相互作用的对映选择性以及 LY295427 对 25-HC 膜紊乱特性的影响,以及 (3) 确定 LY295427 对培养细胞中 25-HC 介导的甾醇稳态反应的对映选择性抑制。该项目的长期目标是阐明维持细胞胆固醇平衡的分子机制,并深入了解如何利用膜结构的改变来传递调节信号。拟议的研究可能有助于确定操纵胆固醇细胞处理和治疗动脉粥样硬化的药理学靶点。 公共健康相关性:高水平的血浆脂蛋白胆固醇(例如低密度脂蛋白 (LDL))与动脉粥样硬化和心脏病有关。了解细胞和全身胆固醇水平的调节机制将为开发降低胆固醇的治疗方法提供新方法,并可能减少心血管疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Agata Agnieszka Bielska其他文献

Agata Agnieszka Bielska的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Agata Agnieszka Bielska', 18)}}的其他基金

Regulation of Cellular Cholesterol Through Oxysterol-Membrane Interactions
通过氧甾醇-膜相互作用调节细胞胆固醇
  • 批准号:
    7999116
  • 财政年份:
    2010
  • 资助金额:
    $ 4.68万
  • 项目类别:

相似海外基金

The influence of 27-hydroxycholesterol on the deterioration of pathology in the lung cancer complicated with interstitial pneumonia
27-羟基胆固醇对肺癌并发间质性肺炎病理恶化的影响
  • 批准号:
    21K08911
  • 财政年份:
    2021
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study
27-羟基胆固醇在乳腺癌中的作用:基于人群的多种族研究
  • 批准号:
    10166556
  • 财政年份:
    2020
  • 资助金额:
    $ 4.68万
  • 项目类别:
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study
27-羟基胆固醇在乳腺癌中的作用:基于人群的多种族研究
  • 批准号:
    10360551
  • 财政年份:
    2019
  • 资助金额:
    $ 4.68万
  • 项目类别:
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study
27-羟基胆固醇在乳腺癌中的作用:基于人群的多种族研究
  • 批准号:
    10581518
  • 财政年份:
    2019
  • 资助金额:
    $ 4.68万
  • 项目类别:
The promotion effect of 27-hydroxycholesterol as selective estrogen receptor modulator on the proliferation of lung cancer
27-羟基胆固醇作为选择性雌激素受体调节剂对肺癌增殖的促进作用
  • 批准号:
    18K08800
  • 财政年份:
    2018
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis
27-羟基胆固醇作为肥胖与乳腺癌发病机制之间的联系
  • 批准号:
    8918538
  • 财政年份:
    2014
  • 资助金额:
    $ 4.68万
  • 项目类别:
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis
27-羟基胆固醇作为肥胖与乳腺癌发病机制之间的联系
  • 批准号:
    8869268
  • 财政年份:
    2014
  • 资助金额:
    $ 4.68万
  • 项目类别:
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis
27-羟基胆固醇作为肥胖与乳腺癌发病机制之间的联系
  • 批准号:
    8424402
  • 财政年份:
    2013
  • 资助金额:
    $ 4.68万
  • 项目类别:
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis
27-羟基胆固醇作为肥胖与乳腺癌发病机制之间的联系
  • 批准号:
    8600895
  • 财政年份:
    2013
  • 资助金额:
    $ 4.68万
  • 项目类别:
Elucidation of the role of 27-hydroxycholesterol in chronic obstructive pulmonary disease
阐明 27-羟基胆固醇在慢性阻塞性肺疾病中的作用
  • 批准号:
    25860652
  • 财政年份:
    2013
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了